Pyxis Oncology, Inc. (PYXS) Tops Q2 EPS by 5c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.29), $0.05 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• Morgan Stanley Upgrades Honeywell Aerospace Inc (HONA) to Overweight
• Klarna shares tumble on weak full-year revenue guidance